180 related articles for article (PubMed ID: 17028170)
1. Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes.
Kieda C; Greferath R; Crola da Silva C; Fylaktakidou KC; Lehn JM; Nicolau C
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15576-81. PubMed ID: 17028170
[TBL] [Abstract][Full Text] [Related]
2. Myo-InositolTrisPyroPhosphate treatment leads to HIF-1α suppression and eradication of early hepatoma tumors in rats.
Aprahamian M; Bour G; Akladios CY; Fylaktakidou K; Greferath R; Soler L; Marescaux J; Egly JM; Lehn JM; Nicolau C
Chembiochem; 2011 Mar; 12(5):777-83. PubMed ID: 21370375
[TBL] [Abstract][Full Text] [Related]
3. myo-Inositol trispyrophosphate: a novel allosteric effector of hemoglobin with high permeation selectivity across the red blood cell plasma membrane.
Duarte CD; Greferath R; Nicolau C; Lehn JM
Chembiochem; 2010 Dec; 11(18):2543-8. PubMed ID: 21086482
[TBL] [Abstract][Full Text] [Related]
4. Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate.
Biolo A; Greferath R; Siwik DA; Qin F; Valsky E; Fylaktakidou KC; Pothukanuri S; Duarte CD; Schwarz RP; Lehn JM; Nicolau C; Colucci WS
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1926-9. PubMed ID: 19204295
[TBL] [Abstract][Full Text] [Related]
5. Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate.
Limani P; Linecker M; Kachaylo E; Tschuor C; Kron P; Schlegel A; Ungethuem U; Jang JH; Georgiopoulou S; Nicolau C; Lehn JM; Graf R; Humar B; Clavien PA
Clin Cancer Res; 2016 Dec; 22(23):5887-5897. PubMed ID: 27489288
[TBL] [Abstract][Full Text] [Related]
6. Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy.
Raykov Z; Grekova SP; Bour G; Lehn JM; Giese NA; Nicolau C; Aprahamian M
Int J Cancer; 2014 Jun; 134(11):2572-82. PubMed ID: 24214898
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells.
Oknińska M; El-Hafny-Rahbi B; Paterek A; Mackiewicz U; Crola-Da Silva C; Brodaczewska K; Mączewski M; Kieda C
J Cell Mol Med; 2020 Feb; 24(3):2272-2283. PubMed ID: 31957267
[TBL] [Abstract][Full Text] [Related]
8. Impact of myo-inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models.
Tran LB; Cao-Pham TT; Jordan BF; Deschoemaeker S; Heyerick A; Gallez B
J Cell Mol Med; 2019 Mar; 23(3):1908-1916. PubMed ID: 30575283
[TBL] [Abstract][Full Text] [Related]
9. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
DeNiro M; Alsmadi O; Al-Mohanna F
Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
[TBL] [Abstract][Full Text] [Related]
10. Tumour angiogenesis normalized by myo-inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response.
El Hafny-Rahbi B; Brodaczewska K; Collet G; Majewska A; Klimkiewicz K; Delalande A; Grillon C; Kieda C
J Cell Mol Med; 2021 Apr; 25(7):3284-3299. PubMed ID: 33624446
[TBL] [Abstract][Full Text] [Related]
11. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of siRNA targeting HIF-1alpha on differentiation of peripheral blood endothelial progenitor cells].
Jiang M; Wang CQ; Wang BY; Huang DJ
Ai Zheng; 2005 Nov; 24(11):1293-300. PubMed ID: 16552951
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.
Tsuzuki T; Okada H; Cho H; Tsuji S; Nishigaki A; Yasuda K; Kanzaki H
Hum Reprod; 2012 Feb; 27(2):523-30. PubMed ID: 22128293
[TBL] [Abstract][Full Text] [Related]
14. Coculture of stem cells from apical papilla and human umbilical vein endothelial cell under hypoxia increases the formation of three-dimensional vessel-like structures in vitro.
Yuan C; Wang P; Zhu L; Dissanayaka WL; Green DW; Tong EH; Jin L; Zhang C
Tissue Eng Part A; 2015 Mar; 21(5-6):1163-72. PubMed ID: 25380198
[TBL] [Abstract][Full Text] [Related]
15. Combined endogenous MR biomarkers to assess changes in tumor oxygenation induced by an allosteric effector of hemoglobin.
Cao-Pham TT; Tran-Ly-Binh A; Heyerick A; Fillée C; Joudiou N; Gallez B; Jordan BF
NMR Biomed; 2020 Feb; 33(2):e4181. PubMed ID: 31762121
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.
Sihn G; Walter T; Klein JC; Queguiner I; Iwao H; Nicolau C; Lehn JM; Corvol P; Gasc JM
FEBS Lett; 2007 Mar; 581(5):962-6. PubMed ID: 17316624
[TBL] [Abstract][Full Text] [Related]
18. Stable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment.
Kieda C; El Hafny-Rahbi B; Collet G; Lamerant-Fayel N; Grillon C; Guichard A; Dulak J; Jozkowicz A; Kotlinowski J; Fylaktakidou KC; Vidal A; Auzeloux P; Miot-Noirault E; Beloeil JC; Lehn JM; Nicolau C
J Mol Med (Berl); 2013 Jul; 91(7):883-99. PubMed ID: 23471434
[TBL] [Abstract][Full Text] [Related]
19. Tumour suppressor PTEN activity is differentially inducible by myo-inositol phosphates.
Grzymajlo K; El Hafny-Rahbi B; Kieda C
J Cell Mol Med; 2023 Mar; 27(6):879-890. PubMed ID: 36852461
[TBL] [Abstract][Full Text] [Related]
20. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
